1. Executive Summary (Confidence: High)

Onconest is a Swiss-based "AI-First" startup that addresses the critical navigational and emotional gaps in the contemporary oncology treatment paradigm.^[13] Founded to provide patients with a secure digital companion, the organization utilizes advanced machine learning trained on doctor-approved medical literature and European clinical guidelines to offer real-time, personalized support.^[14] Onconest has quickly gained traction within the European health-tech accelerator ecosystem, securing participation in both Tenity’s Digital Health Accelerator and the Grit International Female Accelerator.^[15] With an official launch year slated for 2025, the company focuses on empowering patients by democratizing access to clinical information, trial matching, and wellbeing resources, all while maintaining the highest European standards for data privacy (GDPR-native).^[14] By positioning itself at the intersection of clinical precision and human empathy, Onconest seeks to reduce the psychosocial burden of cancer, which is increasingly recognized as a vital component of long-term healthspan and survival in the longevity ecosystem.^[14]